Common Stock, Shares, Issued of PharmaCyte Biotech, Inc. from 30 Apr 2011 to 31 Jul 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
PharmaCyte Biotech, Inc. quarterly Common Stock, Shares, Issued in shares history and change rate from 30 Apr 2011 to 31 Jul 2025.
  • PharmaCyte Biotech, Inc. Common Stock, Shares, Issued for the quarter ending 31 Jul 2025 was 21,672,095, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

PharmaCyte Biotech, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 21,672,095 +17 0% 31 Jul 2025 10-Q 15 Sep 2025 2026 Q1
Q1 2025 21,672,095 +17 0% 30 Apr 2025 10-Q 18 Dec 2025 2026 Q2
Q4 2024 21,672,095 +17 0% 31 Jan 2025 10-Q 17 Mar 2025 2025 Q3
Q3 2024 21,672,095 +17 0% 31 Oct 2024 10-Q 13 Dec 2024 2025 Q2
Q2 2024 21,672,078 0 0% 31 Jul 2024 10-Q 17 Sep 2024 2025 Q1
Q1 2024 21,672,078 +70,000 +0.32% 30 Apr 2024 10-K 11 Aug 2025 2025 FY
Q4 2023 21,672,078 +70,000 +0.32% 31 Jan 2024 10-Q 18 Mar 2024 2024 Q3
Q3 2023 21,672,078 +70,000 +0.32% 31 Oct 2023 10-Q 15 Dec 2023 2024 Q2
Q2 2023 21,672,078 +70,029 +0.32% 31 Jul 2023 10-Q 18 Sep 2023 2024 Q1
Q1 2023 21,602,078 +881,031 +4.3% 30 Apr 2023 10-K 13 Aug 2024 2024 FY
Q4 2022 21,602,078 +881,874 +4.3% 31 Jan 2023 10-Q 16 Mar 2023 2023 Q3
Q3 2022 21,602,078 +886,274 +4.3% 31 Oct 2022 10-Q 14 Dec 2022 2022 Q2
Q2 2022 21,602,049 +19,990,378 +1240% 31 Jul 2022 10-Q 14 Sep 2022 2023 Q1
Q1 2022 20,721,047 +19,130,963 +1203% 30 Apr 2022 10-K 31 Jul 2023 2023 FY
Q4 2021 20,720,204 -2,320,690,201 -99% 31 Jan 2022 10-Q 15 Mar 2022 2022 Q3
Q3 2021 20,715,804 -2,314,094,601 -99% 31 Oct 2021 10-Q 14 Dec 2021 2022 Q2
Q2 2021 1,611,671 -1,873,532,067 -100% 31 Jul 2021 10-Q 14 Sep 2021 2022 Q1
Q1 2021 1,590,084 +497,659 30 Apr 2021 10-K 28 Jul 2022 2022 FY
Q4 2020 2,341,410,405 +912,939,233 +64% 31 Jan 2021 10-Q 12 Mar 2021 2021 Q3
Q3 2020 2,334,810,405 +1,002,939,233 +75% 31 Oct 2020 10-Q 11 Dec 2020 2021 Q2
Q2 2020 1,875,143,738 +616,972,566 +49% 31 Jul 2020 10-Q 11 Sep 2020 2021 Q1
Q1 2020 1,092,425* -1,184,912,080 30 Apr 2020 10-K 10 Aug 2021 2021 FY
Q4 2019 1,428,471,172 +301,566,667 +27% 31 Jan 2020 10-Q 13 Mar 2020 2020 Q3
Q3 2019 1,331,871,172 +250,421,212 +23% 31 Oct 2019 10-Q 23 Dec 2019 2020 Q2
Q2 2019 1,258,171,172 +178,671,212 +17% 31 Jul 2019 10-Q 13 Sep 2019 2020 Q1
Q1 2019 1,186,004,505 +172,743,861 +17% 30 Apr 2019 10-K 13 Aug 2020 2020 FY
Q4 2018 1,126,904,505 +146,636,694 +15% 31 Jan 2019 10-Q 14 Mar 2019 2019 Q3
Q3 2018 1,081,449,960 +108,282,149 +11% 31 Oct 2018 10-Q 14 Dec 2018 2019 Q2
Q2 2018 1,079,499,960 +106,332,149 +11% 31 Jul 2018 10-Q 12 Sep 2018 2019 Q1
Q1 2018 1,013,260,644 +107,911,597 +12% 30 Apr 2018 10-K 13 Aug 2019 2019 FY
Q4 2017 980,267,811 +108,029,902 +12% 31 Jan 2018 10-Q 19 Mar 2018 2018 Q3
Q3 2017 973,167,811 +124,013,146 +15% 31 Oct 2017 10-Q 14 Dec 2017 2018 Q2
Q2 2017 973,167,811 +124,513,146 +15% 31 Jul 2017 10-Q 13 Sep 2017 2017 Q1
Q1 2017 905,349,047 +124,115,709 +16% 30 Apr 2017 10-K 20 Jul 2018 2018 FY
Q4 2016 872,237,909 +100,874,083 +13% 31 Jan 2017 10-Q 13 Mar 2017 2017 Q3
Q3 2016 849,154,665 +101,710,921 +14% 31 Oct 2016 10-Q 02 Dec 2016 2017 Q2
Q2 2016 848,654,665 +106,043,836 +14% 31 Jul 2016 10-Q 06 Sep 2016 2017 Q1
Q1 2016 781,233,338 +48,472,802 +6.6% 30 Apr 2016 10-K 27 Jul 2017 2017 FY
Q4 2015 771,363,826 +67,906,033 +9.7% 31 Jan 2016 10-Q 08 Mar 2016 2016 Q3
Q3 2015 747,443,744 +51,332,493 +7.4% 31 Oct 2015 10-Q/A 19 Jan 2016 2016 Q2
Q2 2015 742,610,829 +32,254,615 +4.5% 31 Jul 2015 10-Q/A 19 Jan 2016 2016 Q1
Q1 2015 732,760,536 +42,144,822 +6.1% 30 Apr 2015 10-K 29 Jul 2016 2016 FY
Q4 2014 703,457,793 +100,499,779 +17% 31 Jan 2015 10-Q 13 Mar 2015 2015 Q3
Q3 2014 696,111,251 +107,699,903 +18% 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 710,356,214 +173,414,866 +32% 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 690,615,714 +208,509,366 +43% 30 Apr 2014 10-K/A 19 Jan 2016 2015 FY
Q4 2013 602,958,014 +145,015,189 +32% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q3
Q3 2013 588,411,348 +143,897,097 +32% 31 Oct 2013 10-Q 16 Dec 2013 2014 Q2
Q2 2013 536,941,348 +113,520,497 +27% 31 Jul 2013 10-Q 16 Sep 2013 2014 Q1
Q1 2013 482,106,348 +65,813,153 +16% 30 Apr 2013 10-K 04 Aug 2014 2014 FY
Q4 2012 457,942,825 +83,505,244 +22% 31 Jan 2013 10-Q 26 Mar 2013 2013 Q3
Q3 2012 444,514,251 +70,176,670 +19% 31 Oct 2012 10-Q 26 Dec 2012 2013 Q2
Q2 2012 423,420,851 +50,083,270 +13% 31 Jul 2012 10-Q 19 Sep 2012 2013 Q1
Q1 2012 416,293,195 +59,155,614 +17% 30 Apr 2012 10-K 29 Jul 2013 2013 FY
Q4 2011 374,437,581 31 Jan 2012 10-Q 21 Mar 2012 2012 Q3
Q3 2011 374,337,581 31 Oct 2011 10-Q 15 Dec 2011 2012 Q2
Q2 2011 373,337,581 31 Jul 2011 10-Q/A 20 Sep 2011 2012 Q1
Q1 2011 357,137,581 30 Apr 2011 10-K 14 Aug 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.